Work

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma

Year: 2014

Type: article

Study design: Clinical Trial

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-014-1667-z

Authors: Jennie W. Taylor, Jorg Dietrich, Elizabeth R. Gerstner, Andrew D. Norden, Mikael L. Rinne, Daniel P. Cahill, Anat Stemmer-Rachamimov, Patrick Y. Wen, Rebecca A. Betensky, Diana H. Giorgio, Kellis Snodgrass, Alison E. Randall, Tracy T. Batchelor, Andrew S. Chi

Institutions: Massachusetts General Hospital, Center for Neuro-Oncology, Harvard University, Dana-Farber Brigham Cancer Center, Pfizer (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G458629407, Clinical and Molecular Studies of Malignant Brain Tumors, Training Program in Nervous System Tumors, Targeted Therapies for Glioma, G953382460

OpenAlex ID: W2036388175

FWCI: 2.101

Cites: 27

Cited by: 42

Related to: 10